Skip to main content
Lyell Immunopharma, Inc. logo

Lyell Immunopharma, Inc. — Investor Relations & Filings

Ticker · LYEL ISIN · US55083R1041 US Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2026-04-24 Annual Report
Country US United States of America
Listing US LYEL

About Lyell Immunopharma, Inc.

https://lyell.com/

Lyell Immunopharma, Inc. is a clinical-stage cell therapy company that develops Chimeric Antigen Receptor (CAR) T-cell therapies for cancer. The company pioneers T-cell reprogramming technologies designed to overcome the primary barriers to durable clinical responses in patients. Its scientific approach focuses on enhancing T-cell function and fitness to improve the efficacy and persistence of its therapeutic candidates. Lyell's pipeline targets both solid tumors and hematologic malignancies, addressing significant unmet medical needs in oncology.

Recent filings

Filing Released Lang Actions
ARS - Lyell Immunopharma, Inc. (0001806952) (Filer)
Annual Report
2026-04-24 English
S-3 - Lyell Immunopharma, Inc. (0001806952) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used for registering securities for sale to the public. It includes detailed information about the securities being registered, the selling stockholders, and the terms of the offering. The text references the Securities Act of 1933 and the registration process, and it is clearly a registration statement prospectus rather than a financial report, earnings release, or management discussion. This type of filing is related to capital raising activities and securities registration, which aligns with the Capital/Financing Update category. The document length is substantial (15,000 characters), and it is not merely an announcement of a report but the actual registration statement document. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2026-04-03 English
4 Filing
Director's Dealing
2026-02-12 English
4 Filing
Director's Dealing
2026-02-12 English
4 Filing
Director's Dealing
2026-02-12 English
4 Filing
Director's Dealing
2026-02-11 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.